The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
NCT ID: NCT05920850
Last Updated: 2024-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2023-07-14
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Cancer Screening in High-risk Black Individuals
NCT05898594
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
NCT05987189
Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients
NCT03929926
Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
NCT05024955
CT Scans in Screening for Lung Cancer in Current and Former Smokers
NCT00625690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the 1st session the PN will re-orient participant to the goals and objectives of the project and answer participant questions before starting the intervention. The 1st activity will be to show a 3 minute culturally tailored video that will explain the benefits of lung cancer screening for African American Males (AAM) using an internet-enabled device. After completion of the video, the PN will invite the participant to ask any questions that they have and the PN will offer clarifying information. The PN will review with the participant a culturally adapted shared decision-making tool. The participant will complete the posttest surveys as described abov.
In the 2nd session the PN will determine the scheduling and completion of lung cancer screening and Illinois Tobacco Quit Line (ITQL) engagement. The participant will complete the LDCT screening, navigation needs, Quitline Engagement, and decision change surveys
In the 3rd session the PN will determine scheduling, barriers and completion of lung cancer screening and Quitline engagement. The participant will complete LDCT screening check, and a Quitline engagement check
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
1. A culturally tailored video that provides education about the process of low-dose helical computed tomography (LDCT) lung cancer screening
2. A culturally tailored shared decision-making tool that educates participants about the shared decision-making process
3. The use of a flip chart that reinforces the information provided in the video and shared decision-making tool
4. Navigation support for participants who express interest in LDCT and quitting smoking
Educational Video about LDCT lung cancer screening
A culturally tailored video that provides education about the process LDCT lung cancer screening
A culturally tailored shared decision-making tool
A culturally tailored shared decision-making tool that educates participants about the shared decision-making process
Flip chart
The use of a flip chart that reinforces the information provided in the video and shared decision-making tool
Navigation support
Navigation support for participants who express interest in LDCT and quitting smoking.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Video about LDCT lung cancer screening
A culturally tailored video that provides education about the process LDCT lung cancer screening
A culturally tailored shared decision-making tool
A culturally tailored shared decision-making tool that educates participants about the shared decision-making process
Flip chart
The use of a flip chart that reinforces the information provided in the video and shared decision-making tool
Navigation support
Navigation support for participants who express interest in LDCT and quitting smoking.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Current smokers of any nicotine-containing products
3. Do not self-report a history of lung cancer symptoms
4. Speaks English
Exclusion Criteria
2. Former smokers
3. Self-report a history of lung cancer symptoms
4. Do not speak English
50 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rohan Dexter Jeremiah
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-0273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.